Samukange Washington T, Kafere Chancelar, Heinrich Kristina, Sabblah George T, Siame Mwewa M, Chirinda Libert, Reinhardt Jens, Hilger Anneliese
Division of Major Policy Issues, Coordination, Paul-Ehrlich-Institut, Langen, Germany.
Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Transfus Med Hemother. 2022 Dec 22;50(2):123-128. doi: 10.1159/000528077. eCollection 2023 Apr.
Assuring the quality and safety of blood and blood components is an essential element of health care in all countries and requires government commitment and legal frameworks. Ineffective regulation of blood and blood components has far-reaching consequences that are not limited to the affected countries but also have extensive global implications.
In this review, we summarize the work of the project BloodTrain funded by the German Ministry of Health within the framework of the Global Health Protection Programme to strengthen regulatory structures in Africa that are imperative to guarantee the improved availability, safety, and quality of blood and blood products.
Intense interaction with the stakeholders in African partner countries lead to first measurable successes in the strengthening of blood regulation, as shown here for hemovigilance.
确保血液及血液成分的质量与安全是所有国家医疗保健的基本要素,需要政府的承诺和法律框架。对血液及血液成分监管不力会产生深远影响,不仅限于受影响国家,还具有广泛的全球意义。
在本综述中,我们总结了德国卫生部在全球卫生保护计划框架内资助的“血液列车”项目的工作,该项目旨在加强非洲的监管结构,这对于保证血液及血液制品的可及性、安全性和质量的提高至关重要。
与非洲伙伴国家的利益相关者进行密切互动,在加强血液监管方面取得了首批可衡量的成功,如在此处对血液警戒方面的展示。